Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

The Granulomatosis of Wegener’s

Wolfgang L. Gross, MD, PhD, Antje Mueller, PhD, and Julia Holle, MD  |  May 16, 2011

Delving deeper into the nonvasculitis aspects of the disease

Filed under:ConditionsVasculitis Tagged with:Diagnostic Criteriagranulomatosis with polyangiitisPathogenesisTreatmentWegener's Granulomatosis

RA Treatment May Be Beneficial Even After Patients Meet Remission Criteria

Staff  |  May 16, 2011

An analysis of wrist MRIs from participants in the Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) clinical trial indicates that patients continue to show joint inflammation even after two years of early aggressive therapy.

Filed under:ConditionsFrom the CollegeResearch RheumRheumatoid Arthritis Tagged with:Clinical researchinflammationMRIpatient careRheumatoid Arthritis (RA)

Ethics Forum

Michele Meltzer, MD, MBE, C. Ronald MacKenzie, MD, and Elizabeth A. Kitsis, MD, MBE  |  May 16, 2011

What’s your ongoing obligation to care for patients who can’t pay?

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:Chronic disease managementEthicsHealth InsuranceMedicaidpatient carerheumatologist

Treat Rheumatoid Arthritis to Target

Elana J. Bernstein, MD; Allan Gibofsky, MD, JD  |  April 13, 2011

The time has come for goal-directed management of RA

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:disease managementResearchRheumatoid Arthritis (RA)Treat-to-Target

New Guidance for Rheumatologists who Treat JIA

Kathy Hollimon, Med  |  April 13, 2011

Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Juvenile idiopathic arthritisResearchrheumatologistTreatment

Drug UPDATES

Michele B. Kaufman, PharmD, BCGP  |  March 18, 2011

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsFDASafety

New Criteria for RA Remission

David Holzman  |  February 12, 2011

ACR and EULAR update 1981 criteria to reflect modern treatment options

Filed under:ConditionsRheumatoid Arthritis Tagged with:Classification CriteriaDiagnostic CriteriaGuidelinespatient careRemissionRheumatoid Arthritis (RA)

Chronotherapy with Glucorticoids in Rheumatoid Arthritis

Frank Buttgereit, MD  |  January 17, 2011

Time is of the essence in balancing risks and benefits

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:DrugsglucocorticoidPathogenesisResearchRheumatoid arthritisTreatment

Phoning It In

Bruce N. Cronstein, MD  |  January 17, 2011

The missed message on methotrexate

Filed under:ConditionsDrug Updates Tagged with:DiagnosisMethotrexateTreatment

A Review of Wegener’s Treatment Data

Vanessa Caceres  |  January 17, 2011

Clinical trials show changing role of existing treatment and introduction of newer medications

Filed under:ConditionsResearch RheumVasculitis Tagged with:2010 ACR/ARHP Annual Scientific MeetingDiagnosisgranulamatosis with polyangiitisResearchrheumatologist

  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 107
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences